
A total sum of 25 drugs have been recommended for European use three months into 2022.
The European Medicines Agency’s (EMA) expert committee, the CHMP, has concluded its March meeting, results of which brought the year’s total of new drug recommendations up by five. The drugs have therefore made it one step closer to the official approval, which is granted by the EU Commission.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app